510(k) · Cleared
ClearedBardPort®, SlimPort®, and X-Port® Implanted Ports
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
C.R. Bard, Inc. · LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Cleared on May 20, 2016 as substantially equivalent to K022983 (C.R. Bard, Inc., 2002) and 4 other predicates after a 182-day review. Its family tree reaches back 2 generations to 1987.
- Decided
- May 20, 2016
- Review
- 182 days
- Class
- Class II
- Product code
- LJT
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 2 generations to K873213 (1987). 5 ancestors in all, the oldest K870260 (1987). No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K873213 | Hickman Plastic Subcutaneous Port | C.R. Bard, Inc. | 1987 | 3 |
| −1 | K022983 | Bardport X-Port Isp Port | C.R. Bard, Inc. | 2002 | 1 |
| 0 (this device) | K153359 | BardPort®, SlimPort®, and X-Port® Implanted Ports | C.R. Bard, Inc. | 2016 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1993 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LJT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LJT device
- #1 K251253 PowerPort™ isp Implantable Port; PowerPort™…score 14.9 · 9 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K022983 | Bardport X-Port Isp PortSummary page 4…e: Subcutaneous, Implanted, Intravascular Infusion Port and Catheter Premarket Notification: K022983: BardPort® X-Port® isp Port Manufacturer: Bard Access Systems, Inc. Cur… | 2002 |
| * | K924250 | Plastic Low Profile Subcutaneous PortSummary page 4…e: Subcutaneous, Implanted, Intravascular Infusion Port Predicate and Catheter Devices Premarket Notification: K924250: Plastic Low Profile Subcutaneous Port Manufacturer: Bard Access Systems, Inc.… | 1993 |
| * | K880571 | Cath-Tech Port Implantable Vascular Access SystemSummary page 4…on Name: Subcutaneous, Implanted, Intravascular Infusion Port and Catheter Premarket Notification: K880571: Cath-Tech Port Implantable Vascular Access System Manufactur… | 1988 |
| * | K873213 | Hickman Plastic Subcutaneous PortSummary page 5…e: Subcutaneous, Implanted, Intravascular Infusion Port and Catheter Premarket Notification: K873213: Hickman Plastic Subcutaneous Port Manufacturer: Bard Access Systems, Inc. Predicate… | 1987 |
| * | K870260 | Hickman Titanium Subcutaneous PortSummary page 5…e: Subcutaneous, Implanted, Intravascular Infusion Port and Catheter Premarket Notification: K870260: Hickman Titanium Subcutaneous Port Manufacturer: Bard Access Systems, Inc.… | 1987 |
| † | K081311 | Powerport Implanted Port with Groshong Catheter | 2008 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 29 years and passes through 1 company; a new generation was cleared every 14.9 years on median.
- 2 of the 5 ancestors have a recall of any class.
- 1 other device also cites its predicate K022983.
How does its category compare?
All LJT devicesLJT Port & Catheter, Implanted, Subcutaneous, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.
FDA decisions per year · LJT
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LJT
182in 2016
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LJT
1in 2022
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · LJT
4,308in 2025
MAUDE reports naming product code LJT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 11 | 85 | 1 | 208 |
| 2008 | 7 | 119 | 2 | 161 |
| 2009 | 2 | — | 2 | 172 |
| 2010 | 2 | — | 19 | 207 |
| 2011 | 5 | 144 | 1 | 202 |
| 2012 | 2 | — | 2 | 153 |
| 2013 | 7 | 150 | 0 | 141 |
| 2014 | 2 | — | 0 | 143 |
| 2015 | 4 | 164 | 1 | 149 |
| 2016 | 3 | 182 | 0 | 135 |
| 2017 | 0 | — | 1 | 262 |
| 2018 | 0 | — | 1 | 878 |
| 2019 | 1 | — | 7 | 765 |
| 2020 | 1 | — | 0 | 959 |
| 2021 | 0 | — | 0 | 1,285 |
| 2022 | 0 | — | 1 | 1,334 |
| 2023 | 1 | — | 0 | 1,221 |
| 2024 | 1 | — | 0 | 1,896 |
| 2025 | 2 | — | 0 | 4,308 |
| 2026 | 1 | — | 1 (1) | — |
What is it indicated for?
The BardPort®, SlimPort®, and X-Port® implanted ports are indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medications, I.V. fluids, parenteral nutrition solutions, blood products, and for the withdrawal of blood samples.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K153359 · printed Nov 6, 2026
Cite this page
510(k) Report. “K153359: BardPort®, SlimPort®, and X-Port® Implanted Ports.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K153359
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026